Literature DB >> 9799607

The two-exon gene of the human forkhead transcription factor FREAC-2 (FKHL6) is located at 6p25.3.

A Blixt1, M Mahlapuu, C Bjursell, C Darnfors, T Johannesson, S Enerbäck, P Carlsson.   

Abstract

The gene for the human transcription factor forkhead related activator 2 (FREAC-2; HGMW-approved symbol FKHL6) has been characterized and found to consist of two exons separated by an intron of 3.6 kb. The first exon encodes the forkhead DNA-binding domain and one of the transcriptional activation domains, AD2. The second exon contains the coding sequence corresponding to the C-terminal activation domain AD1. The full-length FREAC-2 protein is predicted to be 444 amino acids, which adds 39 amino acids to the previously published partial cDNA sequence. A 2-kb CG island is centered around the 5' end of the FREAC-2 gene. Fluorescence in situ hybridization was used to localize the human FREAC-2 gene to chromosomal position 6p24-p25, and the localization was further refined by radiation hybrid mapping to 6p25.3. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9799607     DOI: 10.1006/geno.1998.5451

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  6 in total

1.  A spectrum of FOXC1 mutations suggests gene dosage as a mechanism for developmental defects of the anterior chamber of the eye.

Authors:  D Y Nishimura; C C Searby; W L Alward; D Walton; J E Craig; D A Mackey; K Kawase; A B Kanis; S R Patil; E M Stone; V C Sheffield
Journal:  Am J Hum Genet       Date:  2001-01-18       Impact factor: 11.025

2.  Mutation analysis of FOXF2 in patients with disorders of sex development (DSD) in combination with cleft palate.

Authors:  U Jochumsen; R Werner; N Miura; A Richter-Unruh; O Hiort; P M Holterhus
Journal:  Sex Dev       Date:  2009-03-10       Impact factor: 1.824

3.  Disruption of FOXF2 as a Likely Cause of Absent Uvula in an Egyptian Family.

Authors:  R Seselgyte; D Bryant; C Demetriou; M Ishida; E Peskett; N Moreno; D Morrogh; D Sell; M Lees; M Farrall; G E Moore; B Sommerlad; E Pauws; P Stanier
Journal:  J Dent Res       Date:  2019-03-27       Impact factor: 6.116

4.  Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer.

Authors:  Peng-Zhou Kong; Guang-Ming Li; Yin Tian; Bin Song; RuYi Shi
Journal:  Oncotarget       Date:  2016-08-23

Review 5.  FOXF2 acts as a crucial molecule in tumours and embryonic development.

Authors:  Weihan He; Yuanbo Kang; Wei Zhu; Bolun Zhou; Xingjun Jiang; Caiping Ren; Weihua Guo
Journal:  Cell Death Dis       Date:  2020-06-05       Impact factor: 8.469

6.  Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.

Authors:  Nathalie Meyer-Schaller; Chantal Heck; Stefanie Tiede; Mahmut Yilmaz; Gerhard Christofori
Journal:  Breast Cancer Res       Date:  2018-10-01       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.